These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of Paget's disease of bone with salmon calcitonin nasal spray. Gagel RF, Logan C, Mallette LE. J Am Geriatr Soc; 1988 Nov; 36(11):1010-4. PubMed ID: 3171038 [Abstract] [Full Text] [Related]
3. Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease. González D, Vega E, Ghiringhelli G, Mautalen C. Calcif Tissue Int; 1987 Dec; 41(6):313-5. PubMed ID: 3124939 [Abstract] [Full Text] [Related]
5. Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients. Reginster JY, Albert A, Franchimont P. Calcif Tissue Int; 1985 Dec; 37(6):577-80. PubMed ID: 3937575 [Abstract] [Full Text] [Related]
6. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide. Evans RA, Somers NM, Dunstan CR, Hills E, Evans M. Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580 [Abstract] [Full Text] [Related]
12. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin. Rojanasathit S, Rosenberg E, Haddad JG. Lancet; 1974 Dec 14; 2(7894):1412-5. PubMed ID: 4140329 [No Abstract] [Full Text] [Related]
13. [A years' treatment of Paget's disease of bone using salmon calcitonin via nasal spray]. Denis D, Lecart MP, Deroisy R, Jeugmans-Huynen AM, Albert A, Reginster JY, Franchimont P. Rev Med Liege; 1989 Jan 01; 44(1):23-7. PubMed ID: 2916086 [No Abstract] [Full Text] [Related]
15. [Intermittent treatment of Paget's disease of bone with calcitonin: histological study]. Eisinger J, Laponche AM. Rev Rhum Mal Osteoartic; 1976 Jan 01; 43(7-9):511-6. PubMed ID: 981933 [Abstract] [Full Text] [Related]
16. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)]. Trzenschik K, Schmidt UJ, Abendroth K, Ansorg H, Graner H, Lindenhayn K, Schramm G, Kalbe I. Z Alternsforsch; 1978 Jan 01; 33(5):441-51. PubMed ID: 570764 [Abstract] [Full Text] [Related]
17. Synthetic human calcitonin in refractory Paget's disease of bone. Altman RD, Collins-Yudiskas B. Arch Intern Med; 1987 Jul 01; 147(7):1305-8. PubMed ID: 3111398 [Abstract] [Full Text] [Related]
18. Long- and short-term side effects and safety of calcitonin in man: a prospective study. Wimalawansa SJ. Calcif Tissue Int; 1993 Feb 01; 52(2):90-3. PubMed ID: 8443697 [Abstract] [Full Text] [Related]
19. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone. Avramides A, Baker RK, Wallach S. Metabolism; 1974 Nov 01; 23(11):1037-46. PubMed ID: 4472557 [No Abstract] [Full Text] [Related]
20. [Hypocalcemia induced in patients with Paget's disease by nasal salmon calcitonin. Effects of anti-calcitonin salmine antibodies]. Reginster JY, Almer S, Gaspar S, Albert A, Deroisy R, Franchimont P. Rev Rhum Mal Osteoartic; 1989 Jun 01; 56(7):563-7. PubMed ID: 2756322 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]